반응식
CC1C=CC(S(O)(=O)=O)=CC=1.[C:12]([O:15][C:16]1[CH:21]=[CH:20][C:19]([NH:22][NH2:23])=[C:18]([OH:24])[CH:17]=1)(=[O:14])[CH3:13].C(OC1C=CC(N)=C(O)C=1)(=O)C.[Cl:37][CH:38]([C:42](=O)[CH3:43])[C:39](=O)[CH3:40]>>[C:12]([O:15][C:16]1[CH:21]=[CH:20][C:19]([N:22]2[C:42]([CH3:43])=[C:38]([Cl:37])[C:39]([CH3:40])=[N:23]2)=[C:18]([OH:24])[CH:17]=1)(=[O:14])[CH3:13]참가 물질
4
실험 절차
30 mg of the title compound was prepared in a manner similar to Example 54b) by using 4-hydrazinyl-3-hydroxyphenyl acetate 4-methylbenzenesulfonate (0.9 g), which was prepared from 4-amino-3-hydroxyphenyl acetate (1.0 g) in a manner similar to Example 54a), and 3-chloropentane-2,4-dione (1.2 g).
출처 및 근거
- ORD 기록
- ord-1008ad6c6c734e1496f468c928548bbc
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08889727B2
연결된 노트
불러오는 중…